Posted by Michael Wonder on 27 Feb 2017
What Allergan’s CEO thinks about Donald Trump and drug prices
26 February 2017 - Brent Saunders is a man on a mission.
The 47-year-old pharmaceutical chief, whose career has taken him from the top perch at eye care specialist Bausch and Lomb to his current gig as CEO of Allergan, a drug maker with a $90 billion-plus market value, has been snapping up biotechs left and right, challenging the pharmaceutical industry to get its drug pricing house in order, and speaking out on the realities of business in President Donald Trump's America.
Saunders swung by the Fortune offices for a wide-ranging discussion on all of those issues — and more.
